214 related articles for article (PubMed ID: 19627112)
1. Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.
Amero CD; Byerly DW; McElroy CA; Simmons A; Foster MP
Biochemistry; 2009 Aug; 48(32):7595-607. PubMed ID: 19627112
[TBL] [Abstract][Full Text] [Related]
2. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
[TBL] [Abstract][Full Text] [Related]
3. Delineation of alternative conformational states in Escherichia coli peptide deformylase via thermodynamic studies for the binding of actinonin.
Berg AK; Srivastava DK
Biochemistry; 2009 Feb; 48(7):1584-94. PubMed ID: 19191548
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.
Park JK; Moon JH; Kim JH; Kim EE
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jan; 61(Pt 1):150-2. PubMed ID: 16508119
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
[No Abstract] [Full Text] [Related]
6. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
[TBL] [Abstract][Full Text] [Related]
7. Energetic rationale for an unexpected and abrupt reversal of guanidinium chloride-induced unfolding of peptide deformylase.
Berg AK; Manokaran S; Eiler D; Kooren J; Mallik S; Srivastava DK
Protein Sci; 2008 Jan; 17(1):11-5. PubMed ID: 18042674
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
[TBL] [Abstract][Full Text] [Related]
9. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
10. 1H, 13C and 15N NMR assignments of the E. coli peptide deformylase in complex with a natural inhibitor called actinonin.
Larue V; Seijo B; Tisne C; Dardel F
Biomol NMR Assign; 2009 Jun; 3(1):153-5. PubMed ID: 19636969
[TBL] [Abstract][Full Text] [Related]
11. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
[TBL] [Abstract][Full Text] [Related]
12. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structures of Peptide Deformylase from Rice Pathogen Xanthomonas oryzae pv. oryzae in Complex with Substrate Peptides, Actinonin, and Fragment Chemical Compounds.
Ngo HP; Ho TH; Lee I; Tran HT; Sur B; Kim S; Kim JG; Ahn YJ; Cha SS; Kang LW
J Agric Food Chem; 2016 Oct; 64(39):7307-7314. PubMed ID: 27616570
[TBL] [Abstract][Full Text] [Related]
14. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
Apfel C; Banner DW; Bur D; Dietz M; Hirata T; Hubschwerlen C; Locher H; Page MG; Pirson W; Rossé G; Specklin JL
J Med Chem; 2000 Jun; 43(12):2324-31. PubMed ID: 10882358
[TBL] [Abstract][Full Text] [Related]
15. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
Grant SK; Green BG; Kozarich JW
Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
[TBL] [Abstract][Full Text] [Related]
16. Acarbose Potentially Binds to the Type I Peptide Deformylase Catalytic Site and Inhibits Bacterial Growth: An
Singh AK; Prajapati KS; Kumar S
Curr Pharm Des; 2022; 28(35):2890-2900. PubMed ID: 36154601
[TBL] [Abstract][Full Text] [Related]
17. Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.
Zhou Z; Gong W
Acta Crystallogr D Biol Crystallogr; 2004 Jan; 60(Pt 1):137-9. PubMed ID: 14684909
[TBL] [Abstract][Full Text] [Related]
18. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
[TBL] [Abstract][Full Text] [Related]
19. Structure of the Ni(II) complex of Escherichia coli peptide deformylase and suggestions on deformylase activities depending on different metal(II) centres.
Yen NT; Bogdanović X; Palm GJ; Kühl O; Hinrichs W
J Biol Inorg Chem; 2010 Feb; 15(2):195-201. PubMed ID: 20112455
[TBL] [Abstract][Full Text] [Related]
20. Mapping the surface of Escherichia coli peptide deformylase by NMR with organic solvents.
Byerly DW; McElroy CA; Foster MP
Protein Sci; 2002 Jul; 11(7):1850-3. PubMed ID: 12070337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
